| 000 | 01662 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514221905.0 | ||
| 264 | 0 | _c20050630 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a1043-1802 | ||
| 024 | 7 |
_a10.1021/bc049873z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPotrich, C | |
| 245 | 0 | 0 |
_aCytotoxic activity of a tumor protease-activated pore-forming toxin. _h[electronic resource] |
| 260 |
_bBioconjugate chemistry _c |
||
| 300 |
_a369-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCnidarian Venoms _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Linking Reagents |
| 650 | 0 | 4 |
_aCytotoxins _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 650 | 0 | 4 |
_aProdrugs _xchemical synthesis |
| 650 | 0 | 4 |
_aSea Anemones _xchemistry |
| 700 | 1 | _aTomazzolli, R | |
| 700 | 1 | _aDalla Serra, M | |
| 700 | 1 | _aAnderluh, G | |
| 700 | 1 | _aMalovrh, P | |
| 700 | 1 | _aMacek, P | |
| 700 | 1 | _aMenestrina, G | |
| 700 | 1 | _aTejuca, M | |
| 773 | 0 |
_tBioconjugate chemistry _gvol. 16 _gno. 2 _gp. 369-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bc049873z _zAvailable from publisher's website |
| 999 |
_c15441594 _d15441594 |
||